CR-CP Life Science Fund has led the RSV treatment producer’s latest round, participating alongside new and returning backers including Novo and EMS.

The Athenahealth-backed telehealth software provider took its total funding to $125m in a round led by HLM Venture Partners.

Fukuoka Wajiro, SoftBank and Kyushu Power helped pathology imaging system and software provider Medmain raise $10.3m in its second funding round.

The pharmaceutical company has committed $840,000 to Boryung D:HealthCovery, which will work with accelerator Invention Lab.

University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.

Mental health benefits provider Lyra Health once again secured funding from Providence Ventures, as part of a round that pushed its valuation to $1.1bn.

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

Gastrointestinal and liver disease-focused Metacrine has filed to go public having raised $125m from investors including Eli Lilly.

The chronic disease management platform has raised $34.7m in a round led by Bayer, which is also supplying up to $64m in development and milestone payments.